LDX 6.98% 4.0¢ lumos diagnostics holdings limited

So, in the past the CEO said he was going to put FebriDx aside...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,244 Posts.
    lightbulb Created with Sketch. 313
    So, in the past the CEO said he was going to put FebriDx aside and focus on the services business to generate revenue. However, here we are again with another FDA application for FebriDx.

    This should see the share price plummet once more during 2023. Oh, and again, no real update on what's happening with ViraDx. It was supposed to be in the US market months ago. Another false promise by Lumos Diagnostics. Are we surprised? No.

    It looks like there will be no news until early 2024. See you then.
 
watchlist Created with Sketch. Add LDX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.